Andere talen Standard BioTools Inc.

Aandelen

LAB

US34385P1084

Beurs gesloten - Nasdaq Andere beurzen 22:00:01 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,54 ^USD	+2,42%		+4,96%	+14,93%

25/04	Sectorupdate: Aandelen gezondheidszorg dalen aan het eind van de middag	MT
25/04	Sectorupdate: Gezondheidszorg	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Decline Late Afternoon	25/04
Sector Update: Health Care	25/04
Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction	25/04
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024	25/04
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth	25/04
Standard BioTools Inc. Announces Operational Restructuring Plan	25/04
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	08/04
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	08/04
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	04/04
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	04/04
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	03/04
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	18/03
Standard BioTools: Q4 Earnings Snapshot	28/02
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	28/02
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	28/02
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Standard BioTools Inc.

Aandelen

LAB

US34385P1084

Andere talen

Filters